
About Elysium Pharmaceuticals
Elysium Pharmaceuticals is a company based in Vadodara (India) founded in 1996 by Shital Patel. The company has 337 employees.
- Headquarter Vadodara, India
- Employees 337
- Founders Shital Patel
- SectorsHealthcare
- Website elysiumpharma.com
- Social LinkedIn
- Legal Name Elysium Pharmaceuticals Ltd
- Date of Incorporation 11 Jan, 1995
- Jurisdiction Vadodara, Gujarat, India
- Annual Revenue₹160 Cr
FY 2024 · -26% YoY
- Net Profit₹18.35 Cr
FY 2024 · 11% margin
- EBITDA₹37.66 Cr
FY 2024 · 24% margin
- Employee Count337
Associated legal entities of Elysium Pharmaceuticals
Elysium Pharmaceuticals operates through Elysium Pharmaceuticals Ltd (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Elysium Pharmaceuticals Ltd CIN U24231GJ1995PLC024164 | Active | 11 Jan 1995 | Vadodara, Gujarat | ₹160 Cr | 337 | 8 | View details |
Board of directors of Elysium Pharmaceuticals Ltd (Elysium Pharmaceuticals)
Elysium Pharmaceuticals Ltd is the primary company behind Elysium Pharmaceuticals. The board of Elysium Pharmaceuticals Ltd currently have 7 directors; the longest-serving is Vithalbhai Shankerbhai Patel, appointed in 2006. 14 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vithalbhai Shankerbhai Patel DIN 00412203 | Director | 21 Jun 2006 | 20 yrs 3 mo | Elysium Pharmaceuticals Ltd |
| Suhasini Rajnikant Patel DIN 00013506 | Whole-time director | 01 Apr 2012 | 14 yrs 6 mo | Elysium Pharmaceuticals Ltd |
| Yashwantrai Chunibhai Patel DIN 00011865 | Managing Director | 25 Sep 2015 | 11 yrs | Elysium Pharmaceuticals Ltd |
| Jinkal Darshan Patel DIN 08729869 | Whole-time director | 30 Jan 2020 | 6 yrs 8 mo | Elysium Pharmaceuticals Ltd |
| Shitalkumar Navnitbhai Patel DIN 02468307 | Whole-time director | 30 Jan 2020 | 6 yrs 8 mo | Elysium Pharmaceuticals Ltd |
| Chandani Ankitkumar Jhanwar DIN 08895542 | Director | 17 Feb 2023 | 3 yrs 7 mo | Elysium Pharmaceuticals Ltd |
| Hiren Prakash Barot DIN 02468692 | Additional Director | 17 Feb 2025 | 1 yr 7 mo | Elysium Pharmaceuticals Ltd |
People of Elysium Pharmaceuticals
12 people are tracked at Elysium Pharmaceuticals (3 in leadership, 9 in team); the tracked headcount is 337.
| Name | Role | Group |
|---|---|---|
Shital Patel | Founder | Leadership |
Yashwant Patel | Chairman & CEO | Leadership |
| Managing Director | Leadership | |
Dip Bhavsar | Quality Assurance Quality Control | Team |
| Analyst Grade 2 | Team | |
Sandeep Kumawat | Officer | Team |
Padhiyar Harshad | Senior Human Resources Officer | Team |
Munmaya Dash | Engineering Manager | Team |
Arbaaz Bharuchi | Formulation Scientist - II | Team |
Tarun Patel | Manager Formulation Development | Team |
Prakashkumar Devmurari | Senior Executive | Team |
Seema Nakum | Executive HR | Team |
Complete people profiles for Elysium Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Elysium Pharmaceuticals
Figures of Elysium Pharmaceuticals Ltd, the primary company behind Elysium Pharmaceuticals, for FY 2024. Revenue was ₹160 Cr (-26% year on year). Net profit was ₹18.35 Cr (11% margin). EBITDA was ₹37.66 Cr (24% margin). Revenue has grown at a compounded annual rate of -1% over three years and +16% over five years.
- ₹160 CrRevenue · FY 2024 · -26% YoY
- ₹18.35 CrNet profit · 11% margin
- ₹37.66 CrEBITDA · 24% margin
- ₹16.00 CrPaid-up capital
- 337Employees (provident fund records)
- -1%Revenue CAGR, 3 years
- +16%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Elysium Pharmaceuticals Ltd are on its company page.
Detailed financial statements for Elysium Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Elysium Pharmaceuticals
The website of Elysium Pharmaceuticals (elysiumpharma.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 32.8% vs previous month
Similar companies to Elysium Pharmaceuticals
10 companies that operate in the same segment as Elysium Pharmaceuticals (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Elysium Pharmaceuticals
Elysium Pharmaceuticals was founded in 1996.
Elysium Pharmaceuticals is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.
Yashwant Patel is the current CEO of Elysium Pharmaceuticals.
Elysium Pharmaceuticals has 337 employees.
The primary company behind Elysium Pharmaceuticals, Elysium Pharmaceuticals Ltd, reported revenue of βΉ160 Cr for FY 2024, down 26% year on year.
Elysium Pharmaceuticals was founded in 1996 in Vadodara, India, and operates in the heavy machinery sector. Components such as girth gears, sugar mill gears, industrial pinion gears, ring gears, and mill shells are produced for industrial applications. Support rollers, trunnion assemblies, and sponge iron plants are also designed and manufactured. Advanced technologies and quality controls are applied throughout the production process, with operations focused on efficiency and delivery timelines.
Elysium Pharmaceuticals operates through Elysium Pharmaceuticals Ltd.
The legal entities of Elysium Pharmaceuticals currently have 8 directors, including Vithalbhai Shankerbhai Patel, Hiren Prakash Barot, Jinkal Darshan Patel and others.